Gradient

KDA-Asia Pacific region Webinar on the Recent Treatment of Diabetes 2021

(KAPD 2021)

‘The Expanding Role of SGLT2 inhibitor in Asian Patients with T2D’

 
 
Gradient

Faculty

in program

Prof. Kunho Yoon

The Catholic University of Korea
Korea

Prof. Chaicharn Deerochanawong

Rangsit University
Thailand

Prof. Daisuke Yabe

Gifu University
Japan

Prof. Sunghee Choi

Seoul National University
Korea

Prof. Changhee Jung

University of Ulsan
Korea

Programme

Friday 23 April 2021 (KST)

18:30 - 18:50 (KST)

Introduction

Use of SGLT2i in Asian Patients with T2D and Cardio-Renal Diseases

Professor Kunho, YOON

(CV)

18:50 - 19:00

Topic 1 (Commentary)

Interesting Questions about SGLT-2-I Usage

Prof. Chaicharn Deerochanawong (Facilitator)

(CV)

View

19:00 - 19:20

Topic 1 (Lecture)

MOA of SGLT2i in the Aspect of Cardio-Renal-Metabolic (CRM) Benefit

Prof. Daisuke Yabe (Speaker)

(CV)

19:20 - 19:30

Topic 2 (Commentary)

To Identify the Multiple Roles of SGLT2i in Asia

Prof. Sung Hee CHOI (Facilitator)

(CV)

19:30 - 19:50

Topic 2 (Lecture)

Reducing Cardio-Renal Risk with SGLT2i in Patients with T2D: Interpreting the Evidence in Asia's Perspectives

Prof. Changhee JUNG (Speaker)

(CV)

19:50 - 20:20

Q&A

Discussion

20:20 - 20:30

Closing

What is the Best Treatment for T2D in terms of the CRM Diseases?

Kunho Yoon (Chairperson)

 

Webinar Office

#1007, Queen’s Park 12th 194, Gonghang-daero, Gangseo-gu, Seoul (07631), Republic of Korea

82-2-6734-1011

Audience Clapping